help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 70, No. 4 996-999
doi:10.1210/jcem-70-4-996
Copyright © 1990 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SASAKI, A.
Right arrow Articles by YOSHINAGA, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SASAKI, A.
Right arrow Articles by YOSHINAGA, K.

Immunoreactive Corticotropin-Releasing Hormone, Growth Hormone-Releasing Hormone, Somatostatin, and Peptide Histidine Methionine Are Present in Adrenal Pheochromocytomas, but not in Extra-adrenal Pheochromocytoma*

ATSUSHI SASAKI, SHIGERU YUMITA, SHINOBU KIMURA, YUKIO MIURA and KAORU YOSHINAGA

Department of Internal Medicine, Wakayanagi Hospital (A.S.) Miyagi, 989-55 Japan
the Second Department of Internal Medicine, Tohoku University School of Medicine (S.Y., S.K., Y.K., K.Y.) Sendai, 980 Japan

Address all correspondence and requests for reprints to: Atsushi Sasaki, M.D., Department of Internal Medicine, Wakayanagi Hospital, 130-5, Kawakita-Furukawa, Wakayanagi, Miyagi 989-55 Japan.

CRH, GH-releasing hormone (GHRH), soma-tostatin (SRIH), and peptide histidine methionine (PHM) were measured by RIA in extracts of normal adrenal glands and in extracts from adrenal and extraadrenal pheochromocytomas. In normal adrenal glands, immunoreactive (IR) CRH, IR-SRIH, and IR-PHM were detectable, while IR-GHRH was undetectable. In all 11 cases of adrenal pheochromocytomas, the tumors contained 2 or more of these four IR-peptides. In particular, IR-CRH was found in 73% (n = 8) of adrenal pheochromocytomas, IR-GHRH in 91% (n = 10), IR-SRIH in 91% (n = 10), and IR-PHM in 82% (n = 9) of adrenal pheochromocytomas. There was no significant correlation among the concentration of these peptides in each tumor, i.e. the concentrations of the IR-peptides were independent of each other. In contrast to the adrenal pheochromocytomas, none of these 4 IR-peptides was detectable in 5 extraadrenal pheochromocytomas. Gel filtration of pooled extracts from adrenal pheochromocytomas showed that the major component of the IR-CRH, IR-GHRH, IR-SRIH, and IR-PHM eluted in the position of their synthetic counterparts. Our results suggest that 1) the normal adrenal gland contains IR-CRH, IR-SRIH, and IR-PHM, but not IR-GHRH; 2) all of the adrenal pheochromocytomas we examined contained a number of hypothalamic releasing or inhibiting hormones; 3) their tissue concentrations were independent of each other; and 4) all of the extraadrenal pheochromocytomas we examined contained no such IR-peptides. The presence of hypothalamic hormones in adrenal pheochromocytomas and their absence in extraadrenal pheochromocytomas may be due to the differences in the chromaffin cells of their origin. Our data may be helpful in the differential diagnosis between adrenal and extraadrenal pheochromocytomas.

* This work was supported by a Research Grant for Intractable Diseases from the Ministry of Health and Welfare, Japan.

Received March 2, 1989.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
G. Mazzocchi, L. K. Malendowicz, P. Rebuffat, L. Gottardo, and G. G. Nussdorfer
Expression and Function of Vasoactive Intestinal Peptide, Pituitary Adenylate Cyclase-Activating Polypeptide, and Their Receptors in the Human Adrenal Gland
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2575 - 2580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Dermitzaki, C. Tsatsanis, A. Gravanis, and A. N. Margioris
Corticotropin-releasing Hormone Induces Fas Ligand Production and Apoptosis in PC12 Cells via Activation of p38 Mitogen-activated Protein Kinase
J. Biol. Chem., March 29, 2002; 277(14): 12280 - 12287.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
S. L. Smith, A. L. J. Slappy, T. P. Fox, and J. S. Scolapio
Pheochromocytoma Producing Vasoactive Intestinal Peptide
Mayo Clin. Proc., January 1, 2002; 77(1): 97 - 100.
[Abstract] [PDF]


Home page
EndocrinologyHome page
M. Venihaki, K. Ain, E. Dermitzaki, A. Gravanis, and A. N. Margioris
KAT45, a Noradrenergic Human Pheochromocytoma Cell Line Producing Corticotropin-Releasing Hormone
Endocrinology, February 1, 1998; 139(2): 713 - 722.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
B. Y. Wang, L. Gabrilove, D. Pertsemlidis, R. E. Gordon, and P. D. Unger
Oncocytic Pheochromocytoma with Cytokeratin Reactivity: A Case Report with Immunohistochemical and Ultrastructural Studies
International Journal of Surgical Pathology, July 1, 1997; 5(1-2): 61 - 67.
[Abstract] [PDF]


Home page
EndocrinologyHome page
M. Venihaki, A. Gravanis, and A. N. Margioris
Comparative Study between Normal Rat Chromaffin and PC12 Rat Pheochromocytoma Cells: Production and Effects of Corticotropin-Releasing Hormone
Endocrinology, February 1, 1997; 138(2): 698 - 704.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society